RECOMBINANT-HUMAN-ERYTHROPOIETIN REDUCES FREE ERYTHROCYTE PROTOPORPHYRIN LEVELS IN PATIENTS ON CHRONIC DIALYSIS

被引：16
|
作者：
PIAZZA, V
VILLA, G
GALLI, F
SEGAGNI, S
BOVIO, G
POGGIO, F
PICARDI, L
SALVADEO, A
机构：
[1] Div. di Nefrologia ed Emodiali, Fondazione Clinica del Lavoro, I-27100 Pavia
来源：
NEPHRON | 1992年 / 61卷 / 01期
关键词：
ERYTHROPOIETIN; HEME; HEMODIALYSIS; PORPHYRINS;
D O I：
10.1159/000186834
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminum levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminum overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.
引用
收藏
页码：54 / 57
页数：4
相关论文
共 50 条
  • [41] IMPROVEMENT OF HEMORHEOLOGICAL PARAMETERS IN PATIENTS ON HEMODIALYSIS, TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    DELAMAIRE, M
    DURAND, F
    HAMEL, D
    JOYEUX, V
    LEPOGAMP, P
    GENETET, B
    JOURNAL DES MALADIES VASCULAIRES, 1991, 16 (03) : 289 - 294
  • [42] COMPARATIVE PHARMACOKINETICS AND DISTRIBUTION OF HUMAN URINARY ERYTHROPOIETIN AND RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS
    KINOSHITA, H
    OHISHI, N
    KATO, M
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1991, 41-2 (09): : 1004 - 1007
  • [43] REDUCTION IN RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSES BY THE USE OF CHRONIC INTRAVENOUS IRON SUPPLEMENTATION
    FISHBANE, S
    FREI, GL
    MAESAKA, J
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) : 41 - 46
  • [44] THE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HEMOSTASIS AND FIBRINOLYSIS IN HEMODIALYSIS-PATIENTS
    WIRTZ, JJJM
    VANESSER, JWJ
    HAMULYAK, K
    LEUNISSEN, KML
    VANHOOFF, JP
    CLINICAL NEPHROLOGY, 1992, 38 (05) : 277 - 282
  • [45] EFFICACY OF ORAL IRON THERAPY IN PATIENTS RECEIVING RECOMBINANT-HUMAN-ERYTHROPOIETIN
    WINGARD, RL
    PARKER, RA
    ISMAIL, N
    HAKIM, RM
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (03) : 433 - 439
  • [46] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON COAGULATION AND FIBRINOLYSIS IN UREMIC PATIENTS
    CASES, A
    REVERTER, JC
    ESCOLAR, G
    SORRIBES, J
    PEDRET, JL
    REVERT, L
    ORDINAS, A
    NEFROLOGIA, 1994, 14 (01): : 87 - 91
  • [47] PLASMA ENDOTHELIN IN HEMODIALYSIS-PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    BRUNET, P
    LOREC, AM
    LEONETTI, F
    ROUBICEK, C
    JABER, K
    ROUX, F
    BERLAND, Y
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (06) : 650 - 654
  • [48] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL-FUNCTION IN CHRONIC-RENAL-FAILURE PREDIALYSIS PATIENTS
    ROTH, D
    SMITH, RD
    SCHULMAN, G
    STEINMAN, TI
    HATCH, FE
    RUDNICK, MR
    SLOAND, JA
    FREEDMAN, BI
    WILLIAMS, WW
    SHADUR, CA
    BENZ, RL
    TEEHAN, BP
    REVICKI, DA
    SAROKHAN, BJ
    ABELS, RI
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (05) : 777 - 784
  • [49] SUBJECTIVE QUALITY-OF-LIFE ASSESSMENT IN HEMODIALYSIS-PATIENTS AT DIFFERENT LEVELS OF HEMOGLOBIN FOLLOWING USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MCMAHON, LP
    DAWBORN, JK
    AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (03) : 162 - 169
  • [50] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT ON HEMODYNAMIC PARAMETERS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS AND HEMODIALYSIS-PATIENTS
    FERNANDEZ, A
    VEGA, N
    JIMENEZ, F
    MACIA, M
    LARAUDIOGOITIA, E
    HORTAL, L
    PERDOMO, M
    PLAZA, C
    RODRIGUEZ, JC
    PALOP, L
    AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (04) : 207 - 211
12345